What happens when you stop using Wegovy

Step 1: What your body does in the first few weeks after your last dose

Semaglutide has a half-life of around a week, which means it clears from your system gradually rather than all at once. During that washout period, many people notice very little change. The GLP-1 receptor activity that slowed gastric emptying and signalled fullness to the brain fades as blood levels fall, but the process is measured, not sudden.

By weeks three to five after the final injection, most people find that hunger begins to feel familiar again. The sense of fullness that arrived quickly at meals and lasted for hours shortens. Portion sizes that felt comfortable during treatment start to feel less satisfying. This is not a failure of willpower, it reflects the return of appetite-regulating signals to their pre-treatment baseline. The brain's reward response to food, which Wegovy partially dampens, reasserts itself.

Practically, one thing worth doing in this window: step on the scales once a week at the same time of day, noting any trend rather than reacting to daily fluctuation. That habit, which takes under a minute, gives you early, objective data to bring to your prescriber before a small uptick becomes a larger one.

Step 2: What the trial data show about longer-term weight regain

The picture from clinical research is consistent. The STEP 1 trial extension, published in the New England Journal of Medicine, followed participants who had lost an average of around 15% of their body weight during the active treatment phase. After stopping semaglutide and returning to lifestyle support alone, participants regained roughly two-thirds of that weight over the following 52 weeks.

Cardiometabolic improvements (reductions in blood pressure, waist circumference and blood sugar) also partially reversed during the same period, though not always fully. This matters because many people start Wegovy precisely to improve those markers, not just to see a lower number on the scale. The benefits are real; they are also treatment-dependent in many cases.

None of this means the medicine has failed. Obesity is a chronic condition shaped by genetics, hormones and neurological signalling. Treating it for a defined period and then stopping is not unlike pausing blood pressure medication, the underlying condition does not resolve simply because the treatment has ended. The NHS summarises this biology clearly in its patient information on semaglutide.

Step 3: Making a plan before (or just after) you stop

If you are considering stopping, the single most useful step is telling your prescriber before you do. There are several legitimate reasons to discontinue: you have reached your health goals and want to try maintaining them without medication, you are experiencing side effects that outweigh the benefits, cost has become a barrier, or you are planning a pregnancy (Wegovy is not recommended in pregnancy or while breastfeeding, and the MHRA advises a washout period before trying to conceive).

A prescriber can help you think through timing, whether a slower reduction in dose makes sense, and what lifestyle measures to intensify in advance. If cost is the issue, it is worth reading about where to source Wegovy safely in the UK before assuming the only option is to stop entirely. If you have already stopped and weight is creeping back, that is a clinical situation worth discussing too, you are not locked out of restarting. Our free consultation is open to people who paused treatment and want to review their options with a prescriber.

What you should not do is simply trail off without a plan. There is no acute withdrawal syndrome with semaglutide, but an unmanaged stop tends to mean returning habits fill the gap that the medicine had been occupying, and the regain curve steepens quickly. A brief conversation is almost always worth having first. If you want background on what happens when you stop Wegovy, including how your appetite and weight may respond in the weeks that follow, that detail is worth reading before that conversation. If you want background on how the injection works before that conversation, our page on using the Wegovy pen covers the practical and clinical side in detail.

Maintaining progress: what actually helps after stopping

Evidence from the STEP programme and from broader obesity medicine suggests that the people who retain the most benefit after stopping are those who used the treatment window to build sustainable habits, not because habits override biology, but because they reduce the gap between where biology now sits and where behaviour can reach.

Protein intake matters more after stopping: appetite returns and muscle is easier to lose than fat when weight regain begins. Strength-based activity preserves lean mass and modestly supports metabolic rate. Sleep and stress management, often underestimated, both have direct effects on appetite hormones that semaglutide was partly compensating for. If you are weighing up your options, our guides covering what happens if you stop Wegovy and what happens when you stop taking Wegovy walk through the physical and practical consequences in more detail.

For some people, exploring longer-term weight management options, including switching to a different treatment, is the right answer after Wegovy. Tirzepatide (Mounjaro) has a different mechanism and a distinct tolerability profile; some people who found semaglutide difficult or insufficient have had a different experience with it. Whether any of that is appropriate is, again, a clinical conversation, not a decision to make from a search result. Our clinical team reviews every case individually, and you can ask them anything in the free consultation.